Withdrawal-Emergent Dyskinesias following Varenicline Therapy

Varenicline (Chantix[R]) is a nicotinic acetylcholine receptor partial agonist used to aid smoking cessation. Adverse psychiatric and behavioral effects of the drug are recognized and national drug monitoring has included reports of tardive dyskinesia, but no cases have been described in the literat...

Descripción completa

Detalles Bibliográficos
Autores principales: Toffey, Brittany A, Rabin, Marcie, Kurlan, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475689/
https://www.ncbi.nlm.nih.gov/pubmed/26106454
http://dx.doi.org/10.2174/1874205X01509010007
_version_ 1782377495483383808
author Toffey, Brittany A
Rabin, Marcie
Kurlan, Roger
author_facet Toffey, Brittany A
Rabin, Marcie
Kurlan, Roger
author_sort Toffey, Brittany A
collection PubMed
description Varenicline (Chantix[R]) is a nicotinic acetylcholine receptor partial agonist used to aid smoking cessation. Adverse psychiatric and behavioral effects of the drug are recognized and national drug monitoring has included reports of tardive dyskinesia, but no cases have been described in the literature. We now report the first two cases of varenicline-related withdrawal emergent dyskinesias.
format Online
Article
Text
id pubmed-4475689
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-44756892015-06-23 Withdrawal-Emergent Dyskinesias following Varenicline Therapy Toffey, Brittany A Rabin, Marcie Kurlan, Roger Open Neurol J Article Varenicline (Chantix[R]) is a nicotinic acetylcholine receptor partial agonist used to aid smoking cessation. Adverse psychiatric and behavioral effects of the drug are recognized and national drug monitoring has included reports of tardive dyskinesia, but no cases have been described in the literature. We now report the first two cases of varenicline-related withdrawal emergent dyskinesias. Bentham Open 2015-05-29 /pmc/articles/PMC4475689/ /pubmed/26106454 http://dx.doi.org/10.2174/1874205X01509010007 Text en © Toffey et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)
spellingShingle Article
Toffey, Brittany A
Rabin, Marcie
Kurlan, Roger
Withdrawal-Emergent Dyskinesias following Varenicline Therapy
title Withdrawal-Emergent Dyskinesias following Varenicline Therapy
title_full Withdrawal-Emergent Dyskinesias following Varenicline Therapy
title_fullStr Withdrawal-Emergent Dyskinesias following Varenicline Therapy
title_full_unstemmed Withdrawal-Emergent Dyskinesias following Varenicline Therapy
title_short Withdrawal-Emergent Dyskinesias following Varenicline Therapy
title_sort withdrawal-emergent dyskinesias following varenicline therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475689/
https://www.ncbi.nlm.nih.gov/pubmed/26106454
http://dx.doi.org/10.2174/1874205X01509010007
work_keys_str_mv AT toffeybrittanya withdrawalemergentdyskinesiasfollowingvareniclinetherapy
AT rabinmarcie withdrawalemergentdyskinesiasfollowingvareniclinetherapy
AT kurlanroger withdrawalemergentdyskinesiasfollowingvareniclinetherapy

Ejemplares similares